Since the COL3A1 and COL1A2 genes are both in the pathway of scavenging by class A receptors, which are important regulators of immune responses to cancer [62], their co-expression changes in the tumor tissue may help us better understand the immune response processes in breast cancer. This evidence concerns the gene COL3A1 and neoplasm.